In fact, during the course of this study, lumican, COL1A1 and COL6A1 have all been validated independently by Trombetta-Lima et al. as components of the medulloblastoma secreted extracellular matrix, by proteomic and immunohistochemical analysis of patient tumours [54]. The gene discussed is COL1A1; the disease is medulloblastoma.